

Key Takeaways from the Hypertension Pipeline Report Some of the key players contributing to the worldwide anti-hypertensive medication market include Quantum Genomics, Nicox, Santen Pharmaceuticals, Ionis Pharmaceuticals, United Therapeutics Corporation, and several others.ĭelveInsight’s ' Hypertension Pipeline Insight 2022 ' report provides comprehensive global coverage of available, marketed, and pipeline hypertension therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the hypertension pipeline domain. Factors like technological advancement, a growing aging population, and people affected by diabetes, and high blood pressure are favoring the market. 03, 2022 (GLOBE NEWSWIRE) - Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsightĪs per a statement of World Health Organization (WHO), Hypertension is one of the silent killers in 21st century and is one of the biggest global public health concerns.
